News Releases

RESTON, Va. , Jan. 29, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune 500® innovation company, was recently awarded a prime contract by the Advanced Research Projects Agency for Health (ARPA-H). The hybrid firm fixed price/time and materials contract was awarded by the U.S.
January 29, 2024
Jerry Howe to remain employee through June and advisor to Leidos through March 2025 RESTON, Va. , Jan. 17, 2024 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE 500® science and technology leader, today announced the appointment of Dan Antal as General Counsel, effective April 1, 2024 .
January 17, 2024